CoChat

Targeting multiple Alzheimer's disease etiologies with multimodal neuroprotective and neurorestorative iron chelators

The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.

Abstract

Dysregulation of brain iron homeostasis is central to early neuropathological events in Alzhei mer's disease (AD), including oxidative stress, inflam matory processes, amyloid deposition, tau phosphory lation, and neuronal cell cycle regulatory failure, leading to apoptosis. Also, there is a direct link between iron metabolism and AD pathogenesis, demonstrated by the presence of an iron‐responsive element in the 5′ UTR of the amyloid precursor protein transcript. As a consequence of these findings, a new paradigm is emerging that includes the development of iron‐chelating neuroprotective‐neurorescue drugs with multimo dal functions, acting at various pathological brain tar gets. This concept is challenging the widely held assumption that “silver bullet” agents are superior to “dirty drugs” in drug therapy for neurodegenerative diseases. At best, the so‐called magic bullets exhibit moderate symptomatic activity without modifying the course of disease progression. The present review elaborates on conventional and novel therapeutic tar gets of various multifunctional iron‐chelating drugs ( e.g., chemically designed compounds; natural polyphe nols) that address multiple central nervous system etiologies in AD, aimed at preventing or slowing disease evolution. A similar approach in drug design is being investigated for treatment of cancer, AIDS, cardiovas cular diseases, and depression.—Amit, T., Avramovich‐Tirosh, Y., Youdim, M. B. H. Mandel, S. Targeting multiple Alzheimer's disease etiologies with multimodal neuroprotective and neurorestorative iron chelators. FASEB J . 22, 1296–1305 (2008)

Overview

Integrity signals

Registry

Crossref · 10.1096/fj.07-8627rev

Cites

90 of 90 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 90 references

Cited by

See all 134

Metadata

Authors
Amit, T., Avramovich‐Tirosh, Y., Youdim, M. B. H., & Mandel, S.
Affiliations
Technion – Israel Institute of Technology (IL)
Venue
The FASEB Journal
Publisher
Wiley
Published
2007-11-29
Volume
22
Issue
5
Pages
1296-1305
ISSN
  • 0892-6638 (ISSN-L)
  • 1530-6860
OpenAlex
W2072788211
Cited by
126
References
89
Citations by year
2025: 2 · 2024: 3 · 2023: 7 · 2022: 4 · 2021: 6 · 2020: 5 · 2019: 5 · 2018: 5 · 2017: 6 · 2016: 6 · 2015: 6 · 2014: 6 · 2013: 9 · 2012: 12
FWCI
1.05
Type
journal article
Language
en
Open access
closed
Locations
  • The FASEB Journal (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
  • Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
Keywords
Alzheimer's disease, iron chelators, brain iron homeostasis, neuroprotection, neurorestoration, oxidative stress, neuroinflammation, amyloid deposition, tau phosphorylation, neuronal apoptosis, iron-responsive element, amyloid precursor protein, polyphenols, disease-modifying therapy
MeSH terms
Alzheimer Disease, Animals, Brain, Catechin, Cell Cycle, Humans, Hydroxyquinolines, Iron, Iron Chelating Agents, Piperazines, Amyloid beta-Protein Precursor, PC12 Cells, Neuroprotective Agents, Neurodegenerative Diseases, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.